A Phase 1, Randomized, Placebo-Controlled, Double-Blind, Single-Ascending-Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of Intravenous TP-271 in Healthy Adult Subjects

Trial Profile

A Phase 1, Randomized, Placebo-Controlled, Double-Blind, Single-Ascending-Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of Intravenous TP-271 in Healthy Adult Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 12 Sep 2017

At a glance

  • Drugs TP 271 (Primary)
  • Indications Pneumonia
  • Focus Adverse reactions; First in man
  • Sponsors Tetraphase Pharmaceuticals
  • Most Recent Events

    • 05 Jun 2017 Results published in a Tetraphase Pharmaceuticals media release.
    • 05 Jun 2017 According to a Tetraphase Pharmaceuticals media release, data from this single ascending-dose study were presented at the American Society for Microbiology (ASM) Mocrobe 2017.
    • 08 Mar 2017 According to a Tetraphase Pharmaceuticals media release, status changed from recruiting to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top